Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,124,920
+$63,079 QoQ
Shares Held
5,868
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,246
of 3,140 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 93%
Shared 7%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gryphon Financial Partners LLC holds $43,846,091 across 10 Drug Manufacturers - General names. AMGN ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
91,741 | $23,085,705 | |
| 2 | LLY |
ELI LILLY & Co
|
6,418 | $7,697,942 | |
| 3 | JNJ |
Johnson & Johnson
|
25,825 | $6,558,775 | |
| 4 | AMGN |
Amgen Inc
This page
|
5,868 | $2,124,920 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,044 | $2,061,654 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,540 | $826,263 | |
| 7 | GSK |
GSK plc
|
15,580 | $816,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,157 | $239,526 |
All Filings in AMGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,124,920 | 5,868 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,061,841 | 5,860 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,911,163 | 5,839 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,399,429 | 4,959 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,429,554 | 5,120 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,438,114 | 4,616 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,166,362 | 4,475 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,362,947 | 4,230 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,256,673 | 4,022 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,124,200 | 3,954 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,061,064 | 3,684 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $250,483 | 932 | Shares | Sole | 2023-11-07 | |
| 2023-03-31 | $268,100 | 1,109 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $312,540 | 1,190 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $276,565 | 1,227 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $299,987 | 1,233 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $249,073 | 1,030 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $233,967 | 1,040 | Shares | Other | 2022-02-01 | |
| 2021-09-30 | $211,798 | 996 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $267,880 | 1,099 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $251,545 | 1,011 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $223,251 | 971 | Shares | Other | 2021-02-10 | |
| 2020-09-30 | $245,772 | 967 | Shares | Other | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||